[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371122-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371122-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","xrcc1-arg399gln-genetic-variant-increases-colorectal-cancer-susceptibility-a-comprehensive-meta-analysis","XRCC1 Arg399Gln Genetic Variant Increases Colorectal Cancer Susceptibility - A Comprehensive Meta-Analysis","","Colorectal cancer (CRC) remains a highly prevalent and lethal malignancy worldwide. This meta-analysis evaluates the relationship between XRCC1 polymorphisms and CRC susceptibility, focusing on Arg194Trp, Arg280His, and Arg399Gln across 52 case-control studies. Results show a statistically significant association for Arg399Gln with increased CRC risk (OR=1.10, 95% CI=1.01–1.20, p=0.038, random effects). Subgroup analyses by ethnicity indicate no statistical significance for Asian and Caucasian groups, and no publication bias is detected. Overall, XRCC1 Arg399Gln may contribute to heightened CRC susceptibility.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/xrcc1-arg399gln-genetic-variant-increases-colorectal-cancer-susceptibility-a-comprehensive-meta-analysis/371122/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/xrcc1-arg399gln-genetic-variant-increases-colorectal-cancer-susceptibility-a-comprehensive-meta-analysis/371122.png","ImageObject",300,407,{"name":42,"@type":43},"pixelkiddo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which XRCC1 polymorphism was associated with increased colorectal cancer risk?","Question",{"text":63,"@type":64},"The Arg399Gln polymorphism showed a statistically significant increased risk of CRC (OR=1.10, 95% CI=1.01–1.20, p=0.038).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many case-control studies and which XRCC1 polymorphism subgroups were included?",{"text":68,"@type":64},"The meta-analysis combined 52 case-control studies, including 23 Arg194Trp studies, 8 Arg280His studies, and 42 Arg399Gln studies.",{"name":70,"@type":61,"acceptedAnswer":71},"Did the subgroup analysis by ethnicity find significant associations?",{"text":72,"@type":64},"No. Subgroup analysis did not find statistical significance between CRC risk and XRCC1 polymorphisms in Asian and Caucasian populations.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371122,1790278455,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:05/14/2025 Acceptance:11/07/2025 Published:11/22/2025 |\n| --- | --- |\n\nXRCC1 Arg399Gln Genetic Variant Increases Colorectal Cancer Susceptibility: A Comprehensive Meta-Analysis  \nPraveen Kumar Kampalli 1, Mohan Krishna Ghanta2, Rishitha Chowdary Mavillapalli3, Afroz Alam1, Sujatha Peela4, LVKS Bhaskar5 *  \nAbstract  \nIntroduction: Colorectal cancer (CRC) continues to be a common health condition and one of the most prevalent and lethal cancers worldwide. CRC is the third most leading cancer by incidence and second most common cause of cancer mortality. Emerging evidence showing that inherited genetic variants in genes coding for DNA repair enzymes have potential role in increasing the risk ofCRC. Among these, polymorphisms in theXRCC1 has been widely investigated, although the results have been varied in different populations. Methods: The current meta-analysis is aimed to explain the relation between three XRCC1 polymorphisms and the CRC risk. Meta-analysis included a combined analysis of 52 case-controls studies including 23 Arg194Trp studies, 8 Arg280His studies, and 42 Arg399Gln studies. Results: The results of the present study revealed a statistically significant correlation between the Arg399Gln polymorphism and the increased risk ofCRC (OR = 1.10, 95% CI = 1.01–1.20, p = 0.038, random effects model). However, subgroup analysis based on ethnicity revealed no statistical significance between CRC risk and XRCC1 polymorphisms in Asian and Caucasian populations. In addition, no publication bias was found in the current meta-analysis. Conclusion: Overall, the data suggest that XRCC1 Arg399Gln might be associated with increased CRC susceptibility, while Arg194Trp and Arg280His are not significantly associated.  \nKeywords: Colorectal Cancer-XRCC1-Gene-SNP-Meta-analysis  \nAsian Pac J Cancer Prev, 26 (11), 4127-4137  \nIntroduction  \nColorectal cancer (CRC) is known to be a global health burden, both in the terms of incidence and mortality [1, 2] . It is one of the three most frequently diagnosed cancersin the world and the second in cancer-related deaths. According to global estimates in 2020, approximately 1.9 million new cases and 930,000 deaths were reported due to CRC [3, 4] . Incidence rates differ geographically, with higher rates in developed nations and increasing rates in developing countries that are adopting Western lifestyles [5] . Risk factors include obesity, sedentary lifestyle, red meat consumption, alcohol, and tobacco use. Recent data indicate that approximately one in ten CRC cases occurs in individuals aged 50 years or younger, which is a concerning trend [6] . Early detection through screening programs has contributed to reduced mortality in developed countries [7] . Several biomarkers, such as Carcinoembryonic antigen, CA 19-9, microsatellite instability, K-RAS mutations, and BRAF mutations,  \nare used to monitor treatment response, recurrence, and prognosis of colorectal cancer [8] . Treatment options include surgery, chemotherapy, radiation therapy, and targeted therapies.  \nImprovements in the treatment of metastatic CRC have come a long way over the last few decades. Initially 5-flurouracil was used as a chemotherapeutic agent for nearly half a century. Treatment regimens now include additional cytotoxic drugs such as irinotecan, oxaliplatin, and capecitabine, which in turn have opened more targeted treatment options [9, 10] . Combination chemotherapy regimens such as FOLFOX and FOLFIRI have shown improved clinical effectiveness [11] . Moreover, targeted drugs using monoclonal antibodies like bevacizumab, cetuximab, and panitumumabhave shown better treatment outcomes [12, 13]. These targeted agents, when combined with chemotherapy, have shown improved survival ratesand quality of life for metastatic CRC patients [14] . Platinum-based agents such as oxaliplatin via DNA damage mechanisms, mainly by the formation of intra-  \n1Department of Bioscience &","cbCaidw7fylTMK9y","https://ap.wps.com/l/cbCaidw7fylTMK9y","pdf",1320670,"English","# Abstract\n# Introduction\n## Colorectal cancer burden and risk factors\n## Biomarkers and treatment options\n## DNA repair role of XRCC1 and SNP rationale\n# Methods\n# Results\n# Conclusion","[{\"question\":\"Which XRCC1 polymorphism was associated with increased colorectal cancer risk?\",\"answer\":\"The Arg399Gln polymorphism showed a statistically significant increased risk of CRC (OR=1.10, 95% CI=1.01–1.20, p=0.038).\"},{\"question\":\"How many case-control studies and which XRCC1 polymorphism subgroups were included?\",\"answer\":\"The meta-analysis combined 52 case-control studies, including 23 Arg194Trp studies, 8 Arg280His studies, and 42 Arg399Gln studies.\"},{\"question\":\"Did the subgroup analysis by ethnicity find significant associations?\",\"answer\":\"No. Subgroup analysis did not find statistical significance between CRC risk and XRCC1 polymorphisms in Asian and Caucasian populations.\"}]","XRCC1 Arg399Gln Genetic Variant Increases Colorectal Cancer Susceptibility - A Comprehensive Meta-Analysis | PDF",1790191296,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce843f5d829c45b10966efc7203ae904.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91b25cca94d2ae0de0da40424c43dc5a.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e773bb1217309450ec0373a3aa136b6f.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fd5d5b066973ae7ed9cf3a9aa4aa5d5.webp",980,1385]